Of note, at the time of cell death determination, MV-Edm alone had no significant cytotoxicity on HCC cells (Fig. 1c), indicating that the enhanced antitumour effect was mainly contributed by CD8+NKG2D+ cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.